Dr. Agarwal's Health Care Limited — PPTs, 03-02-2026: Investor Presentation

Dr. Agarwal's Health Care demonstrated robust Q3 & 9M FY26 performance.

**Business Performance:** For the nine months, Total Income increased 20.8% YoY to ₹1,548 Cr, while Profit After Tax (PAT) surged 74.3% to ₹118 Cr. EBITDA grew 23.6% to ₹440 Cr, reflecting strong operational efficiency. The company served over 2.2 million patients and performed 238,000+ surgeries, with South India remaining a significant revenue contributor.

**Growth Drivers or Strategy:** As India's largest eye care services chain, the company utilizes a scalable 'hub and spoke' model, enabling deeper market penetration and patient accessibility. A core strategic focus includes clinical excellence, technology-enabled care, and attracting top medical talent.

**Recent Developments:** The company expanded its network significantly, adding 38 facilities year-to-date, with 14 new facilities launched in Q3 FY26 alone.

**Management Commentary / Outlook:** The company has ambitious plans to add another 14 facilities (including 9 surgical centers) in Q4 FY26, signaling continued aggressive network expansion into under-penetrated clusters.